Search Results - "Pietras, R"

Refine Results
  1. 1

    CNS Adverse Effects: From Functional Observation Battery/Irwin Tests to Electrophysiology by Fonck, Carlos, Easter, Alison, Pietras, Mark R, Bialecki, Russell A

    “…This chapter describes various approaches for the preclinical assessment of drug-induced central nervous system (CNS) adverse effects. Traditionally, methods…”
    Get more information
    Journal Article
  2. 2

    Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer by Pegram, Mark D., Konecny, Gottfried E., O'Callaghan, Carminda, Beryt, Malgorzata, Pietras, Richard, Slamon, Dennis J.

    “…Background: Trastuzumab, a humanized anti-HER2 antibody, increases the clinical benefit of first-line chemotherapy in patients with metastatic breast cancers…”
    Get full text
    Journal Article
  3. 3

    Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells by Pietras, Richard J., Márquez, Diana C., Chen, Hsiao-Wang, Tsai, Eugene, Weinberg, Olga, Fishbein, Michael

    Published in Steroids (01-05-2005)
    “…Extranuclear estrogen receptors may mediate rapid effects of estradiol that communicate with nuclear receptors and contribute to proliferation of human cancers…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs by PIETRAS, R. J, PEGRAM, M. D, FINN, R. S, MANEVAL, D. A, SLAMON, D. J

    Published in Oncogene (29-10-1998)
    “…HER-2 oncogene encodes a transmembrane growth factor receptor that is overexpressed in 25-30% of patients with primary breast and ovarian cancer. A murine…”
    Get full text
    Journal Article
  5. 5

    Dimensional changes and creep of silica core ceramics used in investment casting of superalloys by WERESZCZAK, A. A, BREDER, K, FERBER, M. K, KIRKLAND, T. P, PAYZANT, E. A, RAWN, C. J, KRUG, E, LAROCCO, C. L, PIETRAS, R. A, KARAKUS, M

    Published in Journal of materials science (01-10-2002)
    “…Dimensional changes and creep deformation of a silica/zircon (74%/24%, respectively) and a high silica (93% silica and 3% zircon) ceramic were characterized…”
    Get full text
    Journal Article
  6. 6

    Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells by Pietras, R J, Fendly, B M, Chazin, V R, Pegram, M D, Howell, S B, Slamon, D J

    Published in Oncogene (01-07-1994)
    “…Approximately 30% of human breast and ovarian cancers have amplification and/or overexpression of HER-2/neu gene which encodes a cell surface growth-factor…”
    Get more information
    Journal Article
  7. 7

    The combination of green tea and tamoxifen is effective against breast cancer by Sartippour, Maryam R., Pietras, Richard, Marquez-Garban, Diana C., Chen, Hsiao-Wang, Heber, David, Henning, Susanne M., Sartippour, Guilan, Zhang, Liping, Lu, Ming, Weinberg, Olga, Rao, Jian Yu, Brooks, Mai N.

    Published in Carcinogenesis (New York) (01-12-2006)
    “…Epidemiologic data have suggested that green tea may prevent breast cancer. Studies in our laboratory have provided evidence that green tea extract inhibits…”
    Get full text
    Journal Article
  8. 8

    The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells by PEGRAM, M. D, FINN, R. S, ARZOO, K, BERYT, M, PIETRAS, R. J, SLAMON, D. J

    Published in Oncogene (31-07-1997)
    “…Recent studies indicate that oncogenes may be involved in determining the sensitivity of human cancers to chemotherapeutic agents. To define the effect of…”
    Get full text
    Journal Article
  9. 9

    Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells by AGUILAR, Z, AKITA, R. W, FINN, R. S, RAMOS, B. L, PEGRAM, M. D, KABBINAVAR, F. F, PIETRAS, R. J, PISACANE, P, SLIWKOWSKI, M. X, SLAMON, D. J

    Published in Oncogene (28-10-1999)
    “…The heregulins are a family of ligands with ability to induce phosphorylation of the p185HER-2/neu receptor. Various investigators have reported a variety of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells by MARQUEZ, Diana C, PIETRAS, Richard J

    Published in Oncogene (06-09-2001)
    “…Membrane-associated binding sites for estrogen may mediate rapid effects of estradiol-17beta that contribute to proliferation of human breast cancers. After…”
    Get full text
    Journal Article
  12. 12

    New approaches to reverse resistance to hormonal therapy in human breast cancer by Weinberg, Olga K., Marquez-Garban, Diana C., Pietras, Richard J.

    Published in Drug resistance updates (01-08-2005)
    “…Breast cancer is now the most common malignancy diagnosed in women. Growth factor and estrogen receptors elicit tight regulation of breast tumor progression…”
    Get full text
    Journal Article
  13. 13

    Steroid hormone receptors in target cell membranes by Pietras, R J, Nemere, I, Szego, C M

    Published in Endocrine (01-04-2001)
    “…Numerous reports of rapid steroid hormone effects in diverse cell types cannot be explained by the generally prevailing theory that centers on the activity of…”
    Get full text
    Journal Article
  14. 14

    Monoclonal Antibody to HER-2/neu Receptor Modulates Repair of Radiation-induced DNA Damage and Enhances Radiosensitivity of Human Breast Cancer Cells Overexpressing This Oncogene by Pietras, R J, Poen, J C, Gallardo, D, Wongvipat, P N, Lee, HJ, Slamon, D J

    Published in Cancer research (Chicago, Ill.) (15-03-1999)
    “…The management of human breast cancer frequently includes radiation therapy as an important intervention, and improvement in the clinical efficacy of radiation…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Preclinical pharmacology of AZD2327: a highly selective agonist of the δ-opioid receptor by Hudzik, T J, Maciag, C, Smith, M A, Caccese, R, Pietras, M R, Bui, K H, Coupal, M, Adam, L, Payza, K, Griffin, A, Smagin, G, Song, D, Swedberg, M D B, Brown, W

    “…In the present article, we summarize the preclinical pharmacology of 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-N,N-diethylbenzamide…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Effects of the δ opioid agonist AZD2327 upon operant behaviors and assessment of its potential for abuse by Hudzik, T.J., Pietras, M.R., Caccese, R., Bui, K.H., Yocca, F., Paronis, C.A., M.D.B., Swedberg

    Published in Pharmacology, biochemistry and behavior (01-09-2014)
    “…AZD2327 is a brain-penetrant agonist at δ opioid receptors which has antidepressant and anxiolytic properties in a wide array of animal models. As part of the…”
    Get full text
    Journal Article
  19. 19
  20. 20